Axonics Inc reports results for the quarter ended in March - Earnings Summary

Axonics

30/04/2024 22:49

* Axonics Inc  AXNX.OQ  reported a quarterly adjusted loss
of 27
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -19
cents.  The mean expectation of twelve analysts for the quarter
was for a loss of 8 cents per share. Wall Street expected
results to range from -14 cents to -5 cents per share.
    * Revenue rose 29.4% to $91.41 million from a year ago;
analysts
expected $89.94 million. 
    * Axonics Inc's reported EPS for the quarter was a loss
of 38
cents​.
    * The company reported a quarterly loss of $19.11 million.
    * Axonics Inc shares had fallen by 3.0% this quarter and
gained 7.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 24.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 12
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Axonics Inc is
$71.00 
This summary was machine generated from LSEG data April 30 at
09:49 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.08          -0.27          Missed
 Dec. 31 2023      0.06           0.13           Beat
 Sep. 30 2023      -0.05          0.08           Beat
 Jun. 30 2023      -0.11          0.16           Beat